GBSG — Intelligent Bio Solutions Cashflow Statement
0.000.00%
Last trade - 00:00HealthcareMicro Cap
- $7.28m
- $6.64m
- $1.26m
Annual cashflow statement for Intelligent Bio Solutions, fiscal year end - June 30th, USD millions except per share, conversion factor applied.
2019 June 30th | 2020 June 30th | 2021 June 30th | 2022 June 30th | 2023 June 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS/A | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -7.39 | -3.19 | -7.06 | -8.33 | -10.7 |
| Depreciation | |||||
| Non-Cash Items | — | 0.067 | 0.704 | 2.54 | 2.39 |
| Unusual Items | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 1.82 | 2.63 | -4.94 | 2.44 | 0.079 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -5.58 | -0.499 | -11.3 | -3.36 | -7.38 |
| Other Investing Cash Flow Items | 0 | -0.014 | — | -0.88 | -0.694 |
| Acquisition of Business | |||||
| Sale of Business | |||||
| Change in Net Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | 0 | -0.014 | — | -0.88 | -0.694 |
| Financing Cash Flow Items | -0.383 | -0.116 | -2 | 0 | -1.33 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 5.32 | 0.734 | 23.4 | 0 | 1.44 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -0.22 | 0.229 | 12.1 | -4.34 | -6.7 |